Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

Alzheimer's Drug Discovery Foundation calls for guidelines for FDA-approved blood tests to continue momentum toward precision ...

In this video interview, Michael Miller, chief operating officer at Quanterix, highlights neurology and oncology as two ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

A breakthrough new drug could halt the progression of Alzheimer's disease, promising new research suggests.

DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the ...

This year’s 50 Over 50 list features powerful women who are making monumental strides in society through their initiatives ...

Alzheimer’s disease, a neurological disorder that affects memory and cognition, has often been portrayed in global cinema. In Hindi cinema, filmmakers have also taken up the challenge of sensitively ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

Eisai (OTCPK:ESALF) and Eli Lilly (NYSE:LLY) on Wednesday announced data from long-term extension studies for their ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

This Research Topic aims to explore how cellular metabolites (intermediates or end-products of metabolic processes) influence neuronal activity in both ...